Site-Specific Conjugation of Cell Wall Polyrhamnose to Protein SpyAD Envisioning a Safe Universal Group A Streptococcal Vaccine-Reference-Cited by-同舟云学术

Site-Specific Conjugation of Cell Wall Polyrhamnose to Protein SpyAD Envisioning a Safe Universal Group A Streptococcal Vaccine

Published:2020-12-29 Issue:2 Volume:3 Page:87-100
ISSN:2641-5917
Container-title:Infectious Microbes and Diseases
language:en
Short-container-title:

Author:

Gao Nina J.,Uchiyama Satoshi,Pill Lucy,Dahesh Samira,Olson Joshua,Bautista Leslie,Maroju Shilpa,Berges Aym,Liu Janet Z.,Zurich Raymond H.,van Sorge Nina M.,Fairman Jeff,Kapoor Neeraj,Nizet Victor

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference66 articles.

1. The global burden of group A streptococcal diseases;Carapetis;Lancet Infect Dis,2005

2. A regionwide intervention to promote appropriate antibiotic use in children reversed trends in erythromycin resistance to Streptococcus pyogenes;Gagliotti;Acta Paediatr,2015

3. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial;Gerber;JAMA,2013

4. The path to group A Streptococcus vaccines: World Health Organization research and development technology roadmap and preferred product characteristics;Vekemans;Clin Infect Dis,2019

5. Acute poststreptococcal glomerulonephritis: the most common acute glomerulonephritis;VanDeVoorde;Pediatr Rev,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rhamnose Polysaccharide-Decorated Outer Membrane Vesicles as a Vaccine Candidate Targeting Group A Streptococcus fromStreptococcus pyogenesandStreptococcus dysgalactiaesubsp.equisimilis;2024-08-23

2. Respiratory tract infections: an update on the complexity of bacterial diversity, therapeutic interventions and breakthroughs;Archives of Microbiology;2024-08-17

3. Recent Scientific Advancements towards a Vaccine against Group A Streptococcus;Vaccines;2024-03-05

4. A platform for the recombinant production of Group A Streptococcus glycoconjugate vaccines;2024-03-02

5. Unveiling the Group A Streptococcus Vaccine-Based L-Rhamnose from Backbone of Group A Carbohydrate: Current Insight Against Acute Rheumatic Fever to Reduce the Global Burden of Rheumatic Heart Disease;F1000Research;2024-02-22